Journal Menu

• Targeted Cancer Therapy Connect Home
• Articles
• Aims and Scope
• Editorial Board
• Author's Instructions
• Special Issue Guidelines
• Abstracting and Indexing
• Publication Ethics & Integrity Guidelines
• Contact Information
• Open Access Policy
• Copyright and Licensing
• Peer Review Process
• Archiving Policy
• Early Career Researchers
• Special Issues
• Insights
• News

Volumes

SCIFINITI ALERT!

Subscribe for research updates and exclusive content straight to your inbox

Choose Journal Computing&AI Connect Communications & Networks Connect GenoMed Connect Molecular Modeling Connect Biomaterials Connect Targeted Cancer Therapy Connect Digital Dentistry Connect Sustainable Food Connect Cell Therapy & Engineering Connect Sustainable Processes Connect Clinical Pharmacy Connect Evidence Synthesis in Healthcare Connect Pharmaceuticals and Nanotech Connect Ecological & Sustainable Materials Connect Organic & Medicinal Chemistry Connect

Subscribe

Editorial Board

Subramaniam Malarkannan

Editorial Board Member

Affiliation:

Medical College of Wisconsin Milwaukee United States

Interests:

NK cell-mediated immunotherapy, NK cells, metabolic reprogramming, T cell-mediated cellular immunotherapy